Item Type | Name |
Concept
|
Cross-Cultural Comparison
|
Concept
|
Thrombospondins
|
Concept
|
Fatal Outcome
|
Academic Article
|
ADAMTS13: what it does, how it works, and why it's important.
|
Academic Article
|
Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages.
|
Academic Article
|
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.
|
Academic Article
|
Management of immune thrombocytopenia--something old, something new.
|
Academic Article
|
Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency.
|
Academic Article
|
Children with ITP: looking beyond the platelet count.
|
Academic Article
|
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.
|
Academic Article
|
Should all adult patients with diarrhoea-associated HUS receive plasma exchange?
|
Academic Article
|
Drug-induced thrombocytopenia: an updated systematic review, 2012.
|
Academic Article
|
A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry.
|
Academic Article
|
Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States.
|
Academic Article
|
Forecasting the future for patients with hereditary TTP.
|
Academic Article
|
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia.
|
Academic Article
|
Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes.
|
Academic Article
|
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods.
|
Academic Article
|
Drug-induced thrombocytopenia in children.
|
Academic Article
|
Irinotecan-induced immune thrombocytopenia.
|
Academic Article
|
Syndromes of thrombotic microangiopathy.
|
Academic Article
|
Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura.
|
Academic Article
|
Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised?
|
Academic Article
|
Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.
|
Academic Article
|
Successful kidney transplantation in a patient with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).
|
Academic Article
|
Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy.
|
Academic Article
|
Platelet Counts during Pregnancy.
|
Academic Article
|
The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: key findings at enrollment until 2017.
|
Academic Article
|
Embolic stroke of undetermined source in a young woman.
|
Academic Article
|
Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future.
|
Academic Article
|
Hereditary Thrombotic Thrombocytopenic Purpura.
|
Academic Article
|
Survival and relapse in patients with thrombotic thrombocytopenic purpura.
|
Academic Article
|
Drug-induced thrombocytopenia: an updated systematic review, 2010.
|
Academic Article
|
Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.
|
Academic Article
|
Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.
|
Academic Article
|
Sequence of treatments for adults with primary immune thrombocytopenia.
|
Academic Article
|
Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura.
|
Academic Article
|
Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.
|
Academic Article
|
First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur?
|
Academic Article
|
The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care.
|
Academic Article
|
Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features.
|
Academic Article
|
Pulmonary involvement in patients with thrombotic thrombocytopenic purpura.
|
Academic Article
|
Drug-induced thrombotic microangiopathy: a systematic review of published reports.
|
Academic Article
|
Congenital thrombotic thrombocytopenic purpura related to a novel mutation in ADAMTS13 gene and management during pregnancy.
|
Academic Article
|
Diversity and severity of adverse reactions to quinine: A systematic review.
|
Academic Article
|
Long-term outcomes of health-related quality of life following diverse thrombotic microangiopathy syndromes.
|
Academic Article
|
Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.
|
Academic Article
|
Platelet counts in women with normal pregnancies: A systematic review.
|
Academic Article
|
The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective.
|
Academic Article
|
Platelet Counts during Pregnancy.
|
Academic Article
|
Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018.
|
Academic Article
|
Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura.
|
Academic Article
|
Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
|
Academic Article
|
Treatment of Immune Thrombocytopenia in Adults: Version 2019.
|
Academic Article
|
The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports.
|
Academic Article
|
Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura.
|
Academic Article
|
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
|
Academic Article
|
How I treat patients with thrombotic thrombocytopenic purpura: 2010.
|
Academic Article
|
Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes.
|
Academic Article
|
Fatigue in adult patients with primary immune thrombocytopenia.
|
Academic Article
|
Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011.
|
Academic Article
|
Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
|
Academic Article
|
Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim.
|
Academic Article
|
Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.
|
Academic Article
|
Approach to the diagnosis and management of drug-induced immune thrombocytopenia.
|
Academic Article
|
Syndromes of thrombotic microangiopathy.
|
Academic Article
|
Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014.
|
Academic Article
|
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura.
|
Academic Article
|
Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why?
|
Academic Article
|
Depression in adult patients with primary immune thrombocytopenia.
|
Academic Article
|
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial.
|
Academic Article
|
A postpartum perfect storm.
|
Academic Article
|
The importance of clinical judgment for the diagnosis of thrombotic thrombocytopenic purpura.
|
Academic Article
|
Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist-oncologists.
|
Academic Article
|
TTP: long-term outcomes following recovery.
|
Academic Article
|
Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report.
|
Academic Article
|
Drug-induced thrombocytopenia: 2019 Update of clinical and laboratory data.
|
Academic Article
|
Congenital TTP: toward a turning point.
|
Academic Article
|
American Society of Hematology 2019 guidelines for immune thrombocytopenia.
|
Academic Article
|
Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia.
|
Academic Article
|
Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia.
|
Academic Article
|
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population.
|
Academic Article
|
ADAMTS13 Alone.
|
Academic Article
|
Systemic infections mimicking thrombotic thrombocytopenic purpura.
|
Academic Article
|
Prevalence of primary immune thrombocytopenia in Oklahoma.
|
Academic Article
|
Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.
|
Academic Article
|
Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists.
|
Academic Article
|
Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura.
|
Academic Article
|
Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency.
|
Academic Article
|
N-Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura.
|
Academic Article
|
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.
|
Academic Article
|
Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device.
|
Academic Article
|
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
|
Academic Article
|
Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.
|
Academic Article
|
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
|
Academic Article
|
The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career.
|
Academic Article
|
Syndromes of thrombotic microangiopathy associated with pregnancy.
|
Academic Article
|
Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.
|
Academic Article
|
Interferon-induced thrombotic microangiopathy.
|
Academic Article
|
After the Party's Over.
|
Academic Article
|
Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
|
Academic Article
|
Diagnosis of thrombotic thrombocytopenic purpura among patients with ADAMTS13 Activity 10%-20.
|
Academic Article
|
Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura.
|
Academic Article
|
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015.
|
Academic Article
|
Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura.
|
Academic Article
|
Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience.
|
Academic Article
|
Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine.
|
Academic Article
|
Drug-induced thrombotic microangiopathy and thrombotic thrombocytopenic purpura: A systematic review, 2018-2023.
|